ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Statistics

Total Valuation

AVBP has a market cap or net worth of $677.58 million. The enterprise value is $360.47 million.

Market Cap	677.58M
Enterprise Value	360.47M

Important Dates

The last earnings date was Wednesday, May 8, 2024, before market open.

Earnings Date	May 8, 2024
Ex-Dividend Date	n/a

Share Statistics

AVBP has 33.49 million shares outstanding. The number of shares has increased by 1,861.24% in one year.

Shares Outstanding	33.49M
Shares Change (YoY)	+1,861.24%
Shares Change (QoQ)	+1,069.88%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.13
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 32.82, with a Debt / Equity ratio of 0.00.

Current Ratio	32.82
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.86M
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (1Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	17.64
200-Day Moving Average	n/a
Relative Strength Index (RSI)	73.61
Average Volume (30 Days)	172,635

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	n/a
Pretax Income	n/a
Net Income	-74.58M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	-$2.23

Balance Sheet

The company has $317.39 million in cash and $285,000 in debt, giving a net cash position of $317.11 million or $9.47 per share.

Cash & Cash Equivalents	317.39M
Total Debt	285,000
Net Cash	317.11M
Net Cash Per Share	$9.47
Equity / Book Value	317.72M
Book Value Per Share	9.49
Working Capital	317.50M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVBP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,861.24%
Shareholder Yield	-1,861.24%
Earnings Yield	-11.01%
FCF Yield	n/a

Analyst Forecast

The average price target for AVBP is $29.25, which is 45.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$29.25
Price Target Difference	45.52%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1